Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study

A higher risk of cardiovascular events has been reported in patients with primary aldosteronism (PA) than in otherwise similar patients with essential hypertension (EH). However, the evidence is limited by small sample size and potential confounding factors. We, therefore, compared the prevalence of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hypertension (Dallas, Tex. 1979) Tex. 1979), 2013-08, Vol.62 (2), p.331-336
Hauptverfasser: Savard, Sébastien, Amar, Laurence, Plouin, Pierre-François, Steichen, Olivier
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 336
container_issue 2
container_start_page 331
container_title Hypertension (Dallas, Tex. 1979)
container_volume 62
creator Savard, Sébastien
Amar, Laurence
Plouin, Pierre-François
Steichen, Olivier
description A higher risk of cardiovascular events has been reported in patients with primary aldosteronism (PA) than in otherwise similar patients with essential hypertension (EH). However, the evidence is limited by small sample size and potential confounding factors. We, therefore, compared the prevalence of cardiovascular events in 459 patients with PA diagnosed in our hypertension unit from 2001 to 2006 and 1290 controls with EH. PA cases and EH controls were individually matched for sex, age (±2 years), and office systolic blood pressure (±10 mm Hg). Patients with PA and EH differed significantly in duration of hypertension, serum potassium, plasma aldosterone and plasma renin concentrations, aldosterone-to-renin ratio, and urinary aldosterone concentration (P
doi_str_mv 10.1161/HYPERTENSIONAHA.113.01060
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1406176887</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1406176887</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3360-f511216a7ba81b204f22d3971f80b6c5bc70312117cd401b3e6f971fc183377e3</originalsourceid><addsrcrecordid>eNpdkNGO1CAUhonRuOPqK5h6YeJN13OAQutd04zOJpvdjbNGvWoopRmUlhFaN_v2Ms6oiSSEcPj-A3yEvEK4QBT4dvP1dv3xbn29vby5rjd1KrILQBDwiKywoDznhWCPyQqw4nmF-OWMPIvxGwByzuVTckaZLBiHckWGRoXe-p8q6sWpkDV-3Dur1Wz9FLM6Rq-tmk2ffbbzLrsNdlThIatd7-Nsgp9sHN9ldYpNc_DOJbAJPsZ8a_ShhXLZdl76h-fkyaBcNC9O6zn59H5912zyq5sPl019lWvGBORDgUhRKNmpEjsKfKC0Z5XEoYRO6KLTElgiUOqeA3bMiOFwqrFkTErDzsmbY9998D8WE-d2tFEb59Rk_BJb5CBQirKUCa2OqD48OJih3R9_1yK0B83tf5pTkbW_Nafsy9M1Szea_m_yj9cEvD4BSaxyQ1CTtvEfJwtZMVYkjh-5e--Sz_jdLfcmtDuj3LxrIQ1ORZlTQAZl2uVpUmC_AIgbl4w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1406176887</pqid></control><display><type>article</type><title>Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study</title><source>Journals@Ovid Ovid Autoload</source><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Savard, Sébastien ; Amar, Laurence ; Plouin, Pierre-François ; Steichen, Olivier</creator><creatorcontrib>Savard, Sébastien ; Amar, Laurence ; Plouin, Pierre-François ; Steichen, Olivier</creatorcontrib><description>A higher risk of cardiovascular events has been reported in patients with primary aldosteronism (PA) than in otherwise similar patients with essential hypertension (EH). However, the evidence is limited by small sample size and potential confounding factors. We, therefore, compared the prevalence of cardiovascular events in 459 patients with PA diagnosed in our hypertension unit from 2001 to 2006 and 1290 controls with EH. PA cases and EH controls were individually matched for sex, age (±2 years), and office systolic blood pressure (±10 mm Hg). Patients with PA and EH differed significantly in duration of hypertension, serum potassium, plasma aldosterone and plasma renin concentrations, aldosterone-to-renin ratio, and urinary aldosterone concentration (P&lt;0.001 for all comparisons). The prevalence of electrocardiographic and echocardiographic left ventricular hypertrophy was about twice higher in patients with PA even after adjustment for hypertension duration. PA patients also had a significantly higher prevalence of coronary artery disease (adjusted odds ratio, 1.9), nonfatal myocardial infarction (adjusted odds ratio, 2.6), heart failure (adjusted odds ratio, 2.9), and atrial fibrillation (adjusted odds ratio, 5.0). The risks associated with PA were similar across levels of serum potassium and plasma aldosterone. To conclude, patients with PA are more likely to have had a cardiovascular complication at diagnosis than otherwise similar patients with EH. Target organ damage and complications disproportionate to blood pressure should be considered as an additional argument for suspecting PA in a given individual and possibly for broadening the scope of screening at the population level.</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/HYPERTENSIONAHA.113.01060</identifier><identifier>PMID: 23753408</identifier><identifier>CODEN: HPRTDN</identifier><language>eng</language><publisher>Hagerstown, MD: American Heart Association, Inc</publisher><subject>Adrenals. Adrenal axis. Renin-angiotensin system (diseases) ; Adult ; Arterial hypertension. Arterial hypotension ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiac dysrhythmias ; Cardiology. Vascular system ; Cardiovascular Diseases - etiology ; Coronary heart disease ; Cross-Sectional Studies ; Endocrinopathies ; Female ; Heart ; Humans ; Hyperaldosteronism - complications ; Hypertension - complications ; Hypertrophy, Left Ventricular - etiology ; Male ; Medical sciences ; Middle Aged ; Non tumoral diseases. Target tissue resistance. Benign neoplasms</subject><ispartof>Hypertension (Dallas, Tex. 1979), 2013-08, Vol.62 (2), p.331-336</ispartof><rights>2013 American Heart Association, Inc</rights><rights>2014 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3360-f511216a7ba81b204f22d3971f80b6c5bc70312117cd401b3e6f971fc183377e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=27579335$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23753408$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Savard, Sébastien</creatorcontrib><creatorcontrib>Amar, Laurence</creatorcontrib><creatorcontrib>Plouin, Pierre-François</creatorcontrib><creatorcontrib>Steichen, Olivier</creatorcontrib><title>Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>A higher risk of cardiovascular events has been reported in patients with primary aldosteronism (PA) than in otherwise similar patients with essential hypertension (EH). However, the evidence is limited by small sample size and potential confounding factors. We, therefore, compared the prevalence of cardiovascular events in 459 patients with PA diagnosed in our hypertension unit from 2001 to 2006 and 1290 controls with EH. PA cases and EH controls were individually matched for sex, age (±2 years), and office systolic blood pressure (±10 mm Hg). Patients with PA and EH differed significantly in duration of hypertension, serum potassium, plasma aldosterone and plasma renin concentrations, aldosterone-to-renin ratio, and urinary aldosterone concentration (P&lt;0.001 for all comparisons). The prevalence of electrocardiographic and echocardiographic left ventricular hypertrophy was about twice higher in patients with PA even after adjustment for hypertension duration. PA patients also had a significantly higher prevalence of coronary artery disease (adjusted odds ratio, 1.9), nonfatal myocardial infarction (adjusted odds ratio, 2.6), heart failure (adjusted odds ratio, 2.9), and atrial fibrillation (adjusted odds ratio, 5.0). The risks associated with PA were similar across levels of serum potassium and plasma aldosterone. To conclude, patients with PA are more likely to have had a cardiovascular complication at diagnosis than otherwise similar patients with EH. Target organ damage and complications disproportionate to blood pressure should be considered as an additional argument for suspecting PA in a given individual and possibly for broadening the scope of screening at the population level.</description><subject>Adrenals. Adrenal axis. Renin-angiotensin system (diseases)</subject><subject>Adult</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiac dysrhythmias</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Coronary heart disease</subject><subject>Cross-Sectional Studies</subject><subject>Endocrinopathies</subject><subject>Female</subject><subject>Heart</subject><subject>Humans</subject><subject>Hyperaldosteronism - complications</subject><subject>Hypertension - complications</subject><subject>Hypertrophy, Left Ventricular - etiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Non tumoral diseases. Target tissue resistance. Benign neoplasms</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkNGO1CAUhonRuOPqK5h6YeJN13OAQutd04zOJpvdjbNGvWoopRmUlhFaN_v2Ms6oiSSEcPj-A3yEvEK4QBT4dvP1dv3xbn29vby5rjd1KrILQBDwiKywoDznhWCPyQqw4nmF-OWMPIvxGwByzuVTckaZLBiHckWGRoXe-p8q6sWpkDV-3Dur1Wz9FLM6Rq-tmk2ffbbzLrsNdlThIatd7-Nsgp9sHN9ldYpNc_DOJbAJPsZ8a_ShhXLZdl76h-fkyaBcNC9O6zn59H5912zyq5sPl019lWvGBORDgUhRKNmpEjsKfKC0Z5XEoYRO6KLTElgiUOqeA3bMiOFwqrFkTErDzsmbY9998D8WE-d2tFEb59Rk_BJb5CBQirKUCa2OqD48OJih3R9_1yK0B83tf5pTkbW_Nafsy9M1Szea_m_yj9cEvD4BSaxyQ1CTtvEfJwtZMVYkjh-5e--Sz_jdLfcmtDuj3LxrIQ1ORZlTQAZl2uVpUmC_AIgbl4w</recordid><startdate>201308</startdate><enddate>201308</enddate><creator>Savard, Sébastien</creator><creator>Amar, Laurence</creator><creator>Plouin, Pierre-François</creator><creator>Steichen, Olivier</creator><general>American Heart Association, Inc</general><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201308</creationdate><title>Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study</title><author>Savard, Sébastien ; Amar, Laurence ; Plouin, Pierre-François ; Steichen, Olivier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3360-f511216a7ba81b204f22d3971f80b6c5bc70312117cd401b3e6f971fc183377e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adrenals. Adrenal axis. Renin-angiotensin system (diseases)</topic><topic>Adult</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiac dysrhythmias</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Coronary heart disease</topic><topic>Cross-Sectional Studies</topic><topic>Endocrinopathies</topic><topic>Female</topic><topic>Heart</topic><topic>Humans</topic><topic>Hyperaldosteronism - complications</topic><topic>Hypertension - complications</topic><topic>Hypertrophy, Left Ventricular - etiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Non tumoral diseases. Target tissue resistance. Benign neoplasms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Savard, Sébastien</creatorcontrib><creatorcontrib>Amar, Laurence</creatorcontrib><creatorcontrib>Plouin, Pierre-François</creatorcontrib><creatorcontrib>Steichen, Olivier</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Savard, Sébastien</au><au>Amar, Laurence</au><au>Plouin, Pierre-François</au><au>Steichen, Olivier</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>2013-08</date><risdate>2013</risdate><volume>62</volume><issue>2</issue><spage>331</spage><epage>336</epage><pages>331-336</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><coden>HPRTDN</coden><abstract>A higher risk of cardiovascular events has been reported in patients with primary aldosteronism (PA) than in otherwise similar patients with essential hypertension (EH). However, the evidence is limited by small sample size and potential confounding factors. We, therefore, compared the prevalence of cardiovascular events in 459 patients with PA diagnosed in our hypertension unit from 2001 to 2006 and 1290 controls with EH. PA cases and EH controls were individually matched for sex, age (±2 years), and office systolic blood pressure (±10 mm Hg). Patients with PA and EH differed significantly in duration of hypertension, serum potassium, plasma aldosterone and plasma renin concentrations, aldosterone-to-renin ratio, and urinary aldosterone concentration (P&lt;0.001 for all comparisons). The prevalence of electrocardiographic and echocardiographic left ventricular hypertrophy was about twice higher in patients with PA even after adjustment for hypertension duration. PA patients also had a significantly higher prevalence of coronary artery disease (adjusted odds ratio, 1.9), nonfatal myocardial infarction (adjusted odds ratio, 2.6), heart failure (adjusted odds ratio, 2.9), and atrial fibrillation (adjusted odds ratio, 5.0). The risks associated with PA were similar across levels of serum potassium and plasma aldosterone. To conclude, patients with PA are more likely to have had a cardiovascular complication at diagnosis than otherwise similar patients with EH. Target organ damage and complications disproportionate to blood pressure should be considered as an additional argument for suspecting PA in a given individual and possibly for broadening the scope of screening at the population level.</abstract><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>23753408</pmid><doi>10.1161/HYPERTENSIONAHA.113.01060</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0194-911X
ispartof Hypertension (Dallas, Tex. 1979), 2013-08, Vol.62 (2), p.331-336
issn 0194-911X
1524-4563
language eng
recordid cdi_proquest_miscellaneous_1406176887
source Journals@Ovid Ovid Autoload; MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Adrenals. Adrenal axis. Renin-angiotensin system (diseases)
Adult
Arterial hypertension. Arterial hypotension
Biological and medical sciences
Blood and lymphatic vessels
Cardiac dysrhythmias
Cardiology. Vascular system
Cardiovascular Diseases - etiology
Coronary heart disease
Cross-Sectional Studies
Endocrinopathies
Female
Heart
Humans
Hyperaldosteronism - complications
Hypertension - complications
Hypertrophy, Left Ventricular - etiology
Male
Medical sciences
Middle Aged
Non tumoral diseases. Target tissue resistance. Benign neoplasms
title Cardiovascular Complications Associated With Primary Aldosteronism: A Controlled Cross-Sectional Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T19%3A33%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiovascular%20Complications%20Associated%20With%20Primary%20Aldosteronism:%20A%20Controlled%20Cross-Sectional%20Study&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Savard,%20S%C3%A9bastien&rft.date=2013-08&rft.volume=62&rft.issue=2&rft.spage=331&rft.epage=336&rft.pages=331-336&rft.issn=0194-911X&rft.eissn=1524-4563&rft.coden=HPRTDN&rft_id=info:doi/10.1161/HYPERTENSIONAHA.113.01060&rft_dat=%3Cproquest_cross%3E1406176887%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1406176887&rft_id=info:pmid/23753408&rfr_iscdi=true